Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Blog
>
2021
Blog, 2021
Science & Nature Reviews. August 2021. Part II
Here are ChemDiv’s reviews on Nature and Science Journal articles. It is the first part of the August reviews. Today we attract your attention to Drug research, Structural Biology, Physiology, a...
Science & Nature Reviews. August 2021. Part I
Here are ChemDiv’s reviews on Nature and Science Journal articles. It is the first part of the August reviews. Today we attract your attention to Drug research, Structural Biology, Physiology, a...
Science & Nature Reviews. July 2021. Part II
ChemDiv shares reviews on Nature and Science Journal articles that impressed us immensely this month. Here is the second part of the July reviews. Today we focus on Drug research, Neurology, Physi...
Science & Nature Reviews. July 2021. Part I
ChemDiv shares reviews on Nature and Science Journal articles that we found the most exciting this month. Here is the first part of the July reviews. Today we observe Genetic Engineering, Drug res...
Science & Nature reviews, June 2021 Part II
We share reviews on Nature and Science Journal articles that we found the most interesting this month. Here is the second part of the June reviews. Today we observe neurophysiology, drug research,...
Science & Nature reviews, June 2021 Part I
ChemDiv follows trends in biology and chemistry to supply clients with high scientific and up-to-date service. We will share reviews on Nature and Science Journal articles that we found the most i...
CHEMDIV IS NOW A DISCOVERY PARTNER WITH GWYNANT THERAPEUTICS AND CELYN THERAPEUTICS
ChemDiv has been selected as a discovery partner with Gwynant Therapeutics and Celyn Therapeutics and starts to work on novel small molecules for oncology targets.
Our covalent compound library is now available in a ready-to-dock format for BioSolveIT
ChemDiv,Inc.
Combinatorial libraries
Combinatorial libraries: from ligand-receptor recognition to machine-learning
Science & Nature reviews, August 2021 (2)
These are ChemDiv's reviews on Nature and Science Journal articles.
OCULAR DISEASES SMALL MOLECULES LIBRARY
ChemDiv presets a brand new OCULAR DISEASES SMALL MOLECULES LIBRARY (13,000 compounds, 7 targets, 4 diseases)For design of screening library we use emerging Targets.
Innovative treatments for sickle cell disease
In people with sickle cell disease, the structure of hemoglobin, a protein of red blood cells that carries oxygen, is disrupted. Due to a hereditary mutation in such people, hemoglobin does not assemb...
1
2
3
4
5
6
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds